Published in J Cereb Blood Flow Metab on November 02, 2015
Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microglia. Glia (2016) 0.76
Depletion of microglia exacerbates postischemic inflammation and brain injury. J Cereb Blood Flow Metab (2017) 0.76
Ubiquitination mediates Kv1.3 endocytosis as a mechanism for protein kinase C-dependent modulation. Sci Rep (2017) 0.75
Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore. Mol Pharmacol (2017) 0.75
Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats. Transl Stroke Res (2017) 0.75
Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke (1989) 21.77
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science (2005) 14.43
Physiology of microglia. Physiol Rev (2011) 6.99
The immunology of stroke: from mechanisms to translation. Nat Med (2011) 6.53
Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation (2006) 4.61
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A (2000) 4.01
Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology (2007) 3.82
Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci (2011) 3.06
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest (2003) 3.02
Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation. Circ Res (2000) 2.78
Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res (2006) 2.67
Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery (1992) 2.32
The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res (2008) 2.01
Ion channels in innate and adaptive immunity. Annu Rev Immunol (2015) 1.99
Microglial activation in stroke: therapeutic targets. Neurotherapeutics (2010) 1.84
The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest (2008) 1.82
Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol (2011) 1.77
Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke (1989) 1.70
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc Natl Acad Sci U S A (2005) 1.69
Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol Pharmacol (2005) 1.63
Evidence for involvement of both IKCa and SKCa channels in hyperpolarizing responses of the rat middle cerebral artery. Stroke (2006) 1.45
Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. J Biol Chem (2010) 1.37
The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration. J Neurosci (2007) 1.37
Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis. Proc Natl Acad Sci U S A (2010) 1.29
Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab (2005) 1.29
Microglia Kv1.3 channels contribute to their ability to kill neurons. J Neurosci (2005) 1.24
Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK. FASEB J (2006) 1.24
Minocycline development for acute ischemic stroke. Transl Stroke Res (2011) 1.12
The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke. J Cereb Blood Flow Metab (2011) 1.08
Electrophysiological properties of microglial cells in normal and pathologic rat brain slices. Eur J Neurosci (2000) 1.05
The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success. J Neurosurg (2013) 1.00
Distinct physiologic properties of microglia and blood-borne cells in rat brain slices after permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab (2000) 0.97
Statistics in experimental cerebrovascular research: comparison of more than two groups with a continuous outcome variable. J Cereb Blood Flow Metab (2010) 0.90
The role of the microglia in acute CNS injury. Metab Brain Dis (2014) 0.88
Ca(2+)-activated K(+) channel-3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a murine asthma model. Am J Respir Cell Mol Biol (2012) 0.88
IKCa channels are a critical determinant of the slow AHP in CA1 pyramidal neurons. Cell Rep (2015) 0.85
Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke. Stroke (2014) 0.79
The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy. PLoS One (2013) 0.79